MedinCell SA (MDCLF) Stock Statistics & Valuation Metrics
Total Valuation
MedinCell SA has a market cap or net worth of $1.06B. The enterprise value is $731.65M.
- Market Cap
- $1.06B
- Enterprise Value
- $731.65M
Share Statistics
MedinCell SA has 35,972,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 35,972,510
- Owned by Insiders
- ―
- Owned by Institutions
- 2.21%
Financial Efficiency
MedinCell SA’s return on equity (ROE) is -10.21 and return on invested capital (ROIC) is -24.37%.
- Return on Equity (ROE)
- -10.21
- Return on Assets (ROA)
- -0.29
- Return on Invested Capital (ROIC)
- -24.37%
- Return on Capital Employed (ROCE)
- -0.29
- Revenue Per Employee
- 138.45K
- Profits Per Employee
- -221.89K
- Employee Count
- 141
- Asset Turnover
- 0.18
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of MedinCell SA is -28.97. MedinCell SA’s PEG ratio is 0.60.
- PE Ratio
- -28.97
- PS Ratio
- 48.52
- PB Ratio
- 308.89
- Price to FCF
- -36.56
- Price to Operating Cash Flow
- -37.72
- PEG Ratio
- 0.60
Income Statement
In the last 12 months, MedinCell SA had revenue of 19.52M and earned -31.29M in profits. Earnings per share was -0.87.
- Revenue
- 19.52M
- Gross Profit
- 19.52M
- Operating Income
- -25.50M
- Pretax Income
- -36.12M
- Net Income
- -31.29M
- EBITDA
- -23.67M
- Earnings Per Share (EPS)
- -0.87
Cash Flow
In the last 12 months, operating cash flow was -25.09M and capital expenditures -815,000, giving a free cash flow of -25.91M billion.
- Operating Cash Flow
- -25.09M
- Free Cash Flow
- -25.91M
- Free Cash Flow per Share
- -0.72
Dividends & Yields
MedinCell SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.74%
- Earnings Yield
- -3.31%
Stock Price Statistics
- Beta
- -0.53
- 52-Week Price Change
- 333.84%
- 50-Day Moving Average
- 33.65
- 200-Day Moving Average
- 34.20
- Relative Strength Index (RSI)
- 0.00
- Average Volume (3m)
- 620
Important Dates
MedinCell SA upcoming earnings date is Dec 09, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Jun 16, 2026
- Next Earnings Date
- Dec 09, 2026
- Ex-Dividend Date
- ―
Financial Position
MedinCell SA as a current ratio of 4.67, with Debt / Equity ratio of 1873.73%
- Current Ratio
- 4.67
- Quick Ratio
- 4.67
- Debt to Market Cap
- 0.07
- Net Debt to EBITDA
- 0.23
- Interest Coverage Ratio
- -3.87
Taxes
In the past 12 months, MedinCell SA has paid -4.83M in taxes.
- Income Tax
- -4.83M
- Effective Tax Rate
- 0.13
Enterprise Valuation
MedinCell SA EV to EBITDA ratio is -31.11, with an EV/FCF ratio of -36.35.
- EV to Sales
- 48.24
- EV to EBITDA
- -31.11
- EV to Free Cash Flow
- -36.35
- EV to Operating Cash Flow
- -37.53
Balance Sheet
MedinCell SA has $84.82M in cash and marketable securities with $57.41M in debt, giving a net cash position of $27.41M billion.
- Cash & Marketable Securities
- $84.82M
- Total Debt
- $57.41M
- Net Cash
- $27.41M
- Net Cash Per Share
- $0.76
- Tangible Book Value Per Share
- -$0.01
Margins
Gross margin is 51.90%, with operating margin of -130.65%, and net profit margin of -160.30%.
- Gross Margin
- 51.90%
- Operating Margin
- -130.65%
- Pretax Margin
- -185.03%
- Net Profit Margin
- -160.30%
- EBITDA Margin
- -155.09%
- EBIT Margin
- -164.43%
Analyst Forecast
The average price target for MedinCell SA is $35.53, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $35.53
- Price Target Upside
- 17.42% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- -16.88%
- EPS Growth Forecast
- -61.36%
